logo

Ligand Pharmaceuticals Inc (LGND)



Trade LGND now with
  Date
  Headline
9/5/2017 8:03:10 AM Ligand Announces Top-Line Results From Phase 2 Study Of LGD-6972 In Patients With Type 2 Diabetes
8/21/2017 9:01:45 AM Ligand Appoints Nancy Gray To Board
8/18/2017 9:01:11 AM Ligand To Receive $2 Mln From WuXi Biologics For Licensing Clinical-Stage Anti-PD-1 Antibody
8/7/2017 4:03:13 PM Ligand Pharmaceuticals Q2 EPS $0.26 Vs. Loss $0.30 Year Ago
7/17/2017 9:05:02 AM Ligand In Commercial License And Supply Deal With Amgen For Rights To Use Captisol In Formulation Of AMG 330
6/20/2017 9:04:40 AM Ligand’s Partner Melinta Announces FDA Approval Of Baxdela For Acute Bacterial Skin And Skin Structure Infections
6/1/2017 9:01:36 AM Ligand Pharma Signs Worldwide OmniAb Platform License Deal With Surface Oncology
5/9/2017 4:07:16 PM Ligand Pharma Q1 EPS $0.22 Vs. $0.30 Year Ago
4/5/2017 9:04:04 AM Ligand Enters Commercial License And Supply Agreements With Marinus For Captisol-Enabled Ganaxolone
3/28/2017 9:03:07 AM Ligand: Licensing Partner Janssen Files An IND For An Antibody Discovered Using OmniAb Technology